You just read:

Trovagene Announces New Patent Issued for Combination of Onvansertib with Anti-Androgen Drugs to Treat Non-Metastatic and Metastatic Prostate Cancer

News provided by

Trovagene, Inc.

Jan 23, 2019, 08:30 ET